Ms Meleta Marie Taylor, NP - Medicare Nurse Practitioner in Middletown, NY

Ms Meleta Marie Taylor, NP is a medicare enrolled "Nurse Practitioner - Family" in Middletown, New York. Her current practice location is 155 Crystal Run Rd, Middletown, New York. You can reach out to her office (for appointments etc.) via phone at (845) 703-6999.

Ms Meleta Marie Taylor is licensed to practice in New York (license number 333801) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1023116746.

Contact Information

Ms Meleta Marie Taylor, NP
155 Crystal Run Rd,
Middletown, NY 10941-4028
(845) 703-6999
Not Available



Provider's Profile

Full NameMs Meleta Marie Taylor
GenderFemale
SpecialityNurse Practitioner - Family
Location155 Crystal Run Rd, Middletown, New York
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1023116746
  • Provider Enumeration Date: 09/20/2006
  • Last Update Date: 07/16/2014
  Medicare PECOS Information:
  • PECOS PAC ID: 7719996115
  • Enrollment ID: I20060412000656

Medical Identifiers

Medical identifiers for Ms Meleta Marie Taylor such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1023116746NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
363LF0000XNurse Practitioner - Family 333801 (New York)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Ms Meleta Marie Taylor allows following entities to bill medicare on her behalf.
Entity NameSun River Health Inc.
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1568526838
PECOS PAC ID: 6608783568
Enrollment ID: O20040714000375

News Archive

Low-dose aspirin not significantly associated with pregnancy loss

The Effects of Aspirin in Gestation and Reproduction (EAGeR) medical trial has found that, in general, low-dose aspirin is not beneficial for future pregnancy outcomes in women with prior pregnancy loss.

COCIR highlights role of medical technologies in helping prevent cancer-related premature deaths

Today is World Cancer Day 2017, and COCIR is honoured to support its ambition of significantly reducing the illnesses and premature deaths caused by cancer by 20201. COCIR is also proud to highlight the increasingly important role that medical technologies play in achieving these goals, by improving prevention, screening, early diagnosis, treatment, care and palliation of cancers.

Isogenica enters into agreement with Dstl to develop antimicrobial peptide drugs

Isogenica Ltd today announced that it has entered into an agreement with UK Ministry of Defence agency, the Defence Science and Technology Laboratory. The agreement concerns the development of antimicrobial peptide drugs and follows a successful collaboration to identify highly effective antimicrobial peptides which are active against a broad spectrum of bacteria.

Four week old children being fed a poor diet of biscuits, ice-cream and soft drinks

Children as young as four weeks old are being fed a poor diet of biscuits, ice-cream and soft drinks, according to new Australian research.

Fenwal receives FDA marketing clearance for Amicus blood cell separator

Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that the U.S. Food and Drug Administration has granted Fenwal 510(k) clearance to market its Amicus® blood cell separator for collecting human platelets stored in InterSol® platelet additive solution (PAS 3). Fenwal's InterSol® solution was approved by the FDA in December 2009 under a new drug application. It is the first and only platelet additive solution now available in America.

Read more Medical News

› Verified 1 days ago

Entity NameOrange Urgent Care Pllc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1043378151
PECOS PAC ID: 7113014820
Enrollment ID: O20071027000019

News Archive

Low-dose aspirin not significantly associated with pregnancy loss

The Effects of Aspirin in Gestation and Reproduction (EAGeR) medical trial has found that, in general, low-dose aspirin is not beneficial for future pregnancy outcomes in women with prior pregnancy loss.

COCIR highlights role of medical technologies in helping prevent cancer-related premature deaths

Today is World Cancer Day 2017, and COCIR is honoured to support its ambition of significantly reducing the illnesses and premature deaths caused by cancer by 20201. COCIR is also proud to highlight the increasingly important role that medical technologies play in achieving these goals, by improving prevention, screening, early diagnosis, treatment, care and palliation of cancers.

Isogenica enters into agreement with Dstl to develop antimicrobial peptide drugs

Isogenica Ltd today announced that it has entered into an agreement with UK Ministry of Defence agency, the Defence Science and Technology Laboratory. The agreement concerns the development of antimicrobial peptide drugs and follows a successful collaboration to identify highly effective antimicrobial peptides which are active against a broad spectrum of bacteria.

Four week old children being fed a poor diet of biscuits, ice-cream and soft drinks

Children as young as four weeks old are being fed a poor diet of biscuits, ice-cream and soft drinks, according to new Australian research.

Fenwal receives FDA marketing clearance for Amicus blood cell separator

Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that the U.S. Food and Drug Administration has granted Fenwal 510(k) clearance to market its Amicus® blood cell separator for collecting human platelets stored in InterSol® platelet additive solution (PAS 3). Fenwal's InterSol® solution was approved by the FDA in December 2009 under a new drug application. It is the first and only platelet additive solution now available in America.

Read more Medical News

› Verified 1 days ago

Entity NameExcel Urgent Care Of Goshen Pllc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1710132816
PECOS PAC ID: 5496811275
Enrollment ID: O20090303000266

News Archive

Low-dose aspirin not significantly associated with pregnancy loss

The Effects of Aspirin in Gestation and Reproduction (EAGeR) medical trial has found that, in general, low-dose aspirin is not beneficial for future pregnancy outcomes in women with prior pregnancy loss.

COCIR highlights role of medical technologies in helping prevent cancer-related premature deaths

Today is World Cancer Day 2017, and COCIR is honoured to support its ambition of significantly reducing the illnesses and premature deaths caused by cancer by 20201. COCIR is also proud to highlight the increasingly important role that medical technologies play in achieving these goals, by improving prevention, screening, early diagnosis, treatment, care and palliation of cancers.

Isogenica enters into agreement with Dstl to develop antimicrobial peptide drugs

Isogenica Ltd today announced that it has entered into an agreement with UK Ministry of Defence agency, the Defence Science and Technology Laboratory. The agreement concerns the development of antimicrobial peptide drugs and follows a successful collaboration to identify highly effective antimicrobial peptides which are active against a broad spectrum of bacteria.

Four week old children being fed a poor diet of biscuits, ice-cream and soft drinks

Children as young as four weeks old are being fed a poor diet of biscuits, ice-cream and soft drinks, according to new Australian research.

Fenwal receives FDA marketing clearance for Amicus blood cell separator

Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that the U.S. Food and Drug Administration has granted Fenwal 510(k) clearance to market its Amicus® blood cell separator for collecting human platelets stored in InterSol® platelet additive solution (PAS 3). Fenwal's InterSol® solution was approved by the FDA in December 2009 under a new drug application. It is the first and only platelet additive solution now available in America.

Read more Medical News

› Verified 1 days ago

Entity NameExcel Urgent Care Of Fishkill Pllc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1720228067
PECOS PAC ID: 9032267919
Enrollment ID: O20090504000091

News Archive

Low-dose aspirin not significantly associated with pregnancy loss

The Effects of Aspirin in Gestation and Reproduction (EAGeR) medical trial has found that, in general, low-dose aspirin is not beneficial for future pregnancy outcomes in women with prior pregnancy loss.

COCIR highlights role of medical technologies in helping prevent cancer-related premature deaths

Today is World Cancer Day 2017, and COCIR is honoured to support its ambition of significantly reducing the illnesses and premature deaths caused by cancer by 20201. COCIR is also proud to highlight the increasingly important role that medical technologies play in achieving these goals, by improving prevention, screening, early diagnosis, treatment, care and palliation of cancers.

Isogenica enters into agreement with Dstl to develop antimicrobial peptide drugs

Isogenica Ltd today announced that it has entered into an agreement with UK Ministry of Defence agency, the Defence Science and Technology Laboratory. The agreement concerns the development of antimicrobial peptide drugs and follows a successful collaboration to identify highly effective antimicrobial peptides which are active against a broad spectrum of bacteria.

Four week old children being fed a poor diet of biscuits, ice-cream and soft drinks

Children as young as four weeks old are being fed a poor diet of biscuits, ice-cream and soft drinks, according to new Australian research.

Fenwal receives FDA marketing clearance for Amicus blood cell separator

Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that the U.S. Food and Drug Administration has granted Fenwal 510(k) clearance to market its Amicus® blood cell separator for collecting human platelets stored in InterSol® platelet additive solution (PAS 3). Fenwal's InterSol® solution was approved by the FDA in December 2009 under a new drug application. It is the first and only platelet additive solution now available in America.

Read more Medical News

› Verified 1 days ago

Entity NameOrange Medical Care Pc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1033204888
PECOS PAC ID: 9032133061
Enrollment ID: O20090731000458

News Archive

Low-dose aspirin not significantly associated with pregnancy loss

The Effects of Aspirin in Gestation and Reproduction (EAGeR) medical trial has found that, in general, low-dose aspirin is not beneficial for future pregnancy outcomes in women with prior pregnancy loss.

COCIR highlights role of medical technologies in helping prevent cancer-related premature deaths

Today is World Cancer Day 2017, and COCIR is honoured to support its ambition of significantly reducing the illnesses and premature deaths caused by cancer by 20201. COCIR is also proud to highlight the increasingly important role that medical technologies play in achieving these goals, by improving prevention, screening, early diagnosis, treatment, care and palliation of cancers.

Isogenica enters into agreement with Dstl to develop antimicrobial peptide drugs

Isogenica Ltd today announced that it has entered into an agreement with UK Ministry of Defence agency, the Defence Science and Technology Laboratory. The agreement concerns the development of antimicrobial peptide drugs and follows a successful collaboration to identify highly effective antimicrobial peptides which are active against a broad spectrum of bacteria.

Four week old children being fed a poor diet of biscuits, ice-cream and soft drinks

Children as young as four weeks old are being fed a poor diet of biscuits, ice-cream and soft drinks, according to new Australian research.

Fenwal receives FDA marketing clearance for Amicus blood cell separator

Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that the U.S. Food and Drug Administration has granted Fenwal 510(k) clearance to market its Amicus® blood cell separator for collecting human platelets stored in InterSol® platelet additive solution (PAS 3). Fenwal's InterSol® solution was approved by the FDA in December 2009 under a new drug application. It is the first and only platelet additive solution now available in America.

Read more Medical News

› Verified 1 days ago

Entity NameDial Doc Now Medical Group Pc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1386245702
PECOS PAC ID: 4789096967
Enrollment ID: O20201211000862

News Archive

Low-dose aspirin not significantly associated with pregnancy loss

The Effects of Aspirin in Gestation and Reproduction (EAGeR) medical trial has found that, in general, low-dose aspirin is not beneficial for future pregnancy outcomes in women with prior pregnancy loss.

COCIR highlights role of medical technologies in helping prevent cancer-related premature deaths

Today is World Cancer Day 2017, and COCIR is honoured to support its ambition of significantly reducing the illnesses and premature deaths caused by cancer by 20201. COCIR is also proud to highlight the increasingly important role that medical technologies play in achieving these goals, by improving prevention, screening, early diagnosis, treatment, care and palliation of cancers.

Isogenica enters into agreement with Dstl to develop antimicrobial peptide drugs

Isogenica Ltd today announced that it has entered into an agreement with UK Ministry of Defence agency, the Defence Science and Technology Laboratory. The agreement concerns the development of antimicrobial peptide drugs and follows a successful collaboration to identify highly effective antimicrobial peptides which are active against a broad spectrum of bacteria.

Four week old children being fed a poor diet of biscuits, ice-cream and soft drinks

Children as young as four weeks old are being fed a poor diet of biscuits, ice-cream and soft drinks, according to new Australian research.

Fenwal receives FDA marketing clearance for Amicus blood cell separator

Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that the U.S. Food and Drug Administration has granted Fenwal 510(k) clearance to market its Amicus® blood cell separator for collecting human platelets stored in InterSol® platelet additive solution (PAS 3). Fenwal's InterSol® solution was approved by the FDA in December 2009 under a new drug application. It is the first and only platelet additive solution now available in America.

Read more Medical News

› Verified 1 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Ms Meleta Marie Taylor is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Ms Meleta Marie Taylor, NP
155 Crystal Run Rd,
Middletown, NY 10941-4028

Ph: (845) 703-6999
Ms Meleta Marie Taylor, NP
155 Crystal Run Rd,
Middletown, NY 10941-4028

Ph: (845) 703-6999

News Archive

Low-dose aspirin not significantly associated with pregnancy loss

The Effects of Aspirin in Gestation and Reproduction (EAGeR) medical trial has found that, in general, low-dose aspirin is not beneficial for future pregnancy outcomes in women with prior pregnancy loss.

COCIR highlights role of medical technologies in helping prevent cancer-related premature deaths

Today is World Cancer Day 2017, and COCIR is honoured to support its ambition of significantly reducing the illnesses and premature deaths caused by cancer by 20201. COCIR is also proud to highlight the increasingly important role that medical technologies play in achieving these goals, by improving prevention, screening, early diagnosis, treatment, care and palliation of cancers.

Isogenica enters into agreement with Dstl to develop antimicrobial peptide drugs

Isogenica Ltd today announced that it has entered into an agreement with UK Ministry of Defence agency, the Defence Science and Technology Laboratory. The agreement concerns the development of antimicrobial peptide drugs and follows a successful collaboration to identify highly effective antimicrobial peptides which are active against a broad spectrum of bacteria.

Four week old children being fed a poor diet of biscuits, ice-cream and soft drinks

Children as young as four weeks old are being fed a poor diet of biscuits, ice-cream and soft drinks, according to new Australian research.

Fenwal receives FDA marketing clearance for Amicus blood cell separator

Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that the U.S. Food and Drug Administration has granted Fenwal 510(k) clearance to market its Amicus® blood cell separator for collecting human platelets stored in InterSol® platelet additive solution (PAS 3). Fenwal's InterSol® solution was approved by the FDA in December 2009 under a new drug application. It is the first and only platelet additive solution now available in America.

Read more News

› Verified 1 days ago


Nurse Practitioner Nurses in Middletown, NY

Lisa Thayer, N.P.
Nurse Practitioner
Medicare: Medicare Enrolled
Practice Location: 155 Crystal Run Rd, Middletown, NY 10941
Phone: 845-703-6999    Fax: 845-703-6297
Katherine Grace Mcdonald, NP
Nurse Practitioner
Medicare: Accepting Medicare Assignments
Practice Location: 155 Crystal Run Rd, Middletown, NY 10941
Phone: 845-703-6999    Fax: 845-703-6297
Mr. Nearco Rodriguez, FNP-BC
Nurse Practitioner
Medicare: Medicare Enrolled
Practice Location: 707 E Main St, Middletown, NY 10940
Phone: 845-333-7575    Fax: 845-333-7139
Ms. Heather Elizabeth Guinan-clark, MS, MPH, APRN, BC
Nurse Practitioner
Medicare: Not Enrolled in Medicare
Practice Location: 155 Crystal Run Rd, Middletown, NY 10941
Phone: 845-703-6999    Fax: 845-703-6297
Erin Tondini, F-NP
Nurse Practitioner
Medicare: Accepting Medicare Assignments
Practice Location: 111 Maltese Dr, Middletown, NY 10940
Phone: 845-342-4774    
Deborah Sherman, N.P.
Nurse Practitioner
Medicare: Not Enrolled in Medicare
Practice Location: 95 Crystal Run Rd, Middletown, NY 10941
Phone: 845-703-6999    Fax: 845-703-6297

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.